Adoptive Transfer of Anti-CD3–Activated CD4+ T Cells Plus Cyclophosphamide and Liposome-Encapsulated Interleukin-2 Cure Murine MC-38 and 3LL Tumors and Establish Tumor-Specific Immunity

Alterations in Signal Transduction Molecules in T Lymphocytes from Tumor-Bearing Mice

1992 • 650 citations

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.

1982 • 640 citations

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.

1993 • 385 citations

Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma.

1993 • 344 citations

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.

1994 • 287 citations

Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine.

1973 • 229 citations

Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta.

1987 • 172 citations

A Distribution-Free Test for Tumor-Growth Curve Analyses with Application to an Animal Tumor Immunotherapy Experiment

1981 • 172 citations

Characterization of a carcinogen‐induced murine B lymphocyte cell line of C3H/eB origin

1977 • 169 citations

Augmentation of the human immune response by cyclophosphamide.

1982 • 136 citations

Enhanced Metastatic Potential of Tumor Cells Harvested From Spontaneous Metastases of Heterogeneous Murine Tumors<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref><xref ref-type="fn" rid="FN4">4</xref>

1982 • 133 citations

Melanoma‐specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by epstein‐barr virus‐transformed B cells

1994 • 86 citations

In vivo antitumor activity of anti-CD3-induced activated killer cells.

1989 • 69 citations

Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets.

1989 • 61 citations

CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion

1995 • 59 citations

Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.

1992 • 55 citations

Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.

1989 • 51 citations

Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasis.

1991 • 50 citations

Treatment of cancer patients with ex vivo anti-CD3-activated killer cells and interleukin-2.

1993 • 45 citations

Adoptive chemoimmunotherapy of murine leukemia with helper T lymphocyte clones.

1987 • 39 citations

Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-?

1993 • 35 citations

Therapeutic and Toxic Activity of Tumor Necrosis Factor Is Synergistic with Gamma Interferon

1989 • 13 citations

An interactive computer program for the analysis of growth curves

1987 • 9 citations

Importance in timing of cyclophosphamide on the enhancement of interleukin-2-induced cytolysis

1991 • 9 citations

VARCOV: A computer program for the distribution-free analysis of growth and response curves

1984 • 8 citations

Anti-CD3+IL-2-stimulated murine killer cells

1989 • 6 citations

CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion

1995 • 6 citations